Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS).

DHEA significantly reduced the number and prevalence of aneuploidy (chromosomal abnormalities) in embryos.

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned reproductive endocrinologist, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.

Citation Page #: 10;8:140.
Journal: Reproductive Biology and Endocrinology
Author Publication: Gleicher N, Weghofer A, Barad DH.
Publication Link: http://www.rbej.com/content/8/1/140
Date: 2010